$2.36T
Total marketcap
$108.6B
Total volume
BTC 50.76%     ETH 15.64%
Dominance

Hansa Biopharma AB (publ) 0RC7.IL Stock

31.35 SEK {{ price }} 6.379373% {{change_pct}}%
Exchange
IOB
Market Cap
2.06B SEK
LOW - HIGH [24H]
0.0000 - 0.0000 SEK
VOLUME [24H]
300 SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-16.03 SEK

Hansa Biopharma AB (publ) Price Chart

Hansa Biopharma AB (publ) 0RC7.IL Financial and Trading Overview

Hansa Biopharma AB (publ) stock price 31.35 SEK
Previous Close 24.38 SEK
Open 24.14 SEK
Bid 24.12 SEK x 0
Ask 25.34 SEK x 0
Day's Range 23.54 - 24.74 SEK
52 Week Range 20.74 - 76.65 SEK
Volume 1.59K SEK
Avg. Volume 14.99K SEK
Market Cap 1.63B SEK
Beta (5Y Monthly) 1.05042
PE Ratio (TTM) N/A
EPS (TTM) -16.03 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

0RC7.IL Valuation Measures

Enterprise Value 1.21B SEK
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 10.248436
Price/Book (mrq) 7.1157165
Enterprise Value/Revenue 7.616
Enterprise Value/EBITDA -1.774

Trading Information

Hansa Biopharma AB (publ) Stock Price History

Beta (5Y Monthly) 1.05042
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 76.65 SEK
52 Week Low 20.74 SEK
50-Day Moving Average 26.16 SEK
200-Day Moving Average 41.83 SEK

0RC7.IL Share Statistics

Avg. Volume (3 month) 14.99K SEK
Avg. Daily Volume (10-Days) 16.98K SEK
Shares Outstanding 52.67M
Float 38.42M
Short Ratio N/A
% Held by Insiders 9.99%
% Held by Institutions 36.37%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) June 30, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -431.055%
Gross Margin 68.16%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -39.81%
Return on Equity (ttm) -228.62%

Income Statement

Revenue (ttm) 158.7M SEK
Revenue Per Share (ttm) 3.25 SEK
Quarterly Revenue Growth (yoy) 38.89%
Gross Profit (ttm) 116.05M SEK
EBITDA -681211520 SEK
Net Income Avi to Common (ttm) -759228032 SEK
Diluted EPS (ttm) -16.03
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.1B SEK
Total Cash Per Share (mrq) 21.02 SEK
Total Debt (mrq) 865.85M SEK
Total Debt/Equity (mrq) 475.26 SEK
Current Ratio (mrq) 4.095
Book Value Per Share (mrq) 3.474

Cash Flow Statement

Operating Cash Flow (ttm) -625537984 SEK
Levered Free Cash Flow (ttm) -368350112 SEK

Profile of Hansa Biopharma AB (publ)

Country United Kingdom
State N/A
City Lund
Address ScheelevAegen 22
ZIP 223 63
Phone 46 46 16 56 70
Website https://www.hansabiopharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 162

Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments with rare immunological conditions using its proprietary enzyme technology platform. The company's lead drug candidate is Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies. It is also developing Novel immunoglobulin cleaving enzymes for Repeat dosing (NiceR) for the treatment of autoimmune diseases, transplantation, and oncology; and Enzyme based antibody Enhancement (EnzE), which is cancer immunotherapy. The company has a preclinical research collaboration agreement with argenx BV to evaluate the potential of combining imlifidase and efgartigimod to potentially be used in the acute and chronic setting of autoimmune diseases and transplantation. It also has a collaboration with Genethon to develop imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Q&A For Hansa Biopharma AB (publ) Stock

What is a current 0RC7.IL stock price?

Hansa Biopharma AB (publ) 0RC7.IL stock price today per share is 31.35 SEK.

How to purchase Hansa Biopharma AB (publ) stock?

You can buy 0RC7.IL shares on the IOB exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Hansa Biopharma AB (publ)?

The stock symbol or ticker of Hansa Biopharma AB (publ) is 0RC7.IL.

Which industry does the Hansa Biopharma AB (publ) company belong to?

The Hansa Biopharma AB (publ) industry is Biotechnology.

How many shares does Hansa Biopharma AB (publ) have in circulation?

The max supply of Hansa Biopharma AB (publ) shares is 65.79M.

What is Hansa Biopharma AB (publ) Price to Earnings Ratio (PE Ratio)?

Hansa Biopharma AB (publ) PE Ratio is now.

What was Hansa Biopharma AB (publ) earnings per share over the trailing 12 months (TTM)?

Hansa Biopharma AB (publ) EPS is -16.03 SEK over the trailing 12 months.

Which sector does the Hansa Biopharma AB (publ) company belong to?

The Hansa Biopharma AB (publ) sector is Healthcare.